The role of peripheral immunity in ALS: a population‐based study
Open Access
- 22 July 2023
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 10 (9) , 1623-1632
Abstract
Background: Systemic inflammation has been proposed as a relevant mechanism in amyotrophic lateral sclerosis (ALS). Still, comprehensive data on ALS patients' innate and adaptive immune responses and their effect on the clinical phenotype are lacking. Here, we investigate systemic immunity in a population‐based ALS cohort using readily available hematological indexes.Methods: We collected clinical data and the complete blood count (CBC) at diagnosis in ALS patients from the Piemonte and Valle d'Aosta Register for ALS (PARALS) from 2007 to 2019. Leukocytes populations, neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), systemic‐immune‐inflammation index (SII), and lymphocyte‐to‐monocyte ratio (LMR) were derived from CBC. All variables were analyzed for association with clinical features in the entire cohort and then in sex‐ and age‐based subgroups.Results: Neutrophils (P = 0.001) and markers of increased innate immunity (NLR, P = 0.008 and SII, P = 0.006) were associated with a faster disease progression. Similarly, elevated innate immunity correlated with worse pulmonary function and shorter survival. The prognosis in women also correlated with low lymphocytes (P = 0.045) and a decreased LMR (P = 0.013). ALS patients with cognitive impairment exhibited lower monocytes (P = 0.0415).Conclusions and Relevance: The dysregulation of the systemic immune system plays a multifaceted role in ALS. More specifically, an elevated innate immune response is associated with faster progression and reduced survival. Conversely, ALS patients with cognitive impairment showed a reduction in monocyte count. Additionally, immune response varied according to sex and age, thus suggesting that involved immune pathways are patient specific. Further studies will help translate those findings into clinical practice or targeted treatments.Keywords
All Related Versions
Funding Information
- Ministero della Salute (RF‐2016‐02362405)
- Università degli Studi del Piemonte Orientale
This publication has 28 references indexed in Scilit:
- Peripheral monocytes are functionally altered and invade the CNS in ALS patientsActa Neuropathologica, 2016
- Evidence for peripheral immune activation in amyotrophic lateral sclerosisJournal of the Neurological Sciences, 2014
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular CarcinomaClinical Cancer Research, 2014
- Blood-CNS Barrier Impairment in ALS patients versus an animal modelFrontiers in Cellular Neuroscience, 2014
- Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALSJournal of Clinical Investigation, 2012
- Alterations of T cell subsets in ALS: a systemic immune activation?Acta Neurologica Scandinavica, 2011
- Innate or Adaptive Immunity? The Example of Natural Killer CellsScience, 2011
- Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory processJournal of Neuroimmunology, 2009
- Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS)Journal of Neuroimmunology, 2005
- Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsetsActa Neurologica Scandinavica, 1988